SALK INSTITUTE FOR BIOLOGICAL STUDIES: Form 990, tax year 2022

View the entire original 990 at ProPublica ↗

Organization
SALK INSTITUTE FOR BIOLOGICAL STUDIES (EIN 95-2160097)
Tax period
2022-07-01 to 2023-06-30
Filed
2024-05-09
IRS object ID
202441309349302309
Schema version
2022v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2024-05-09T11:33:11+00:00ReturnTs
Tax Period End2023-06-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN346565596PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1ERNST & YOUNG US LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1101 E WASHINGTON STAddressLine1Txt
CityPHOENIXCityNm
State AbbreviationAZStateAbbreviationCd
ZIP85004ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2022-07-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN952160097EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1The Salk Institute for Biological StudiesBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlSALKBusinessNameControlTxt
Phone8584534100PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line110010 N TORREY PINES ROADAddressLine1Txt
CityLA JOLLACityNm
State AbbreviationCAStateAbbreviationCd
ZIP920371002ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonKIMBERLY M CASTILLOPersonNm
Person TitleCFOPersonTitleTxt
Phone8584534100PhoneNum
Signature2024-05-09SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstKIMBERLYPersonFirstNm
Person LastCASTILLOPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (true)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonSteven T RuttiPreparerPersonNm
PTINP00775456PTIN
Phone6023223000PhoneNum
Preparation2023-05-15PreparationDt
FieldValueIRS element (for citing)
Tax2022TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

Principal Ofcr Business Name PrincipalOfcrBusinessName

FieldValueIRS element (for citing)
Business Name Line1GERALD JOYCEBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line110010 N TORREY PINES ROADAddressLine1Txt
CityLA JOLLACityNm
State AbbreviationCAStateAbbreviationCd
ZIP920371002ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$332,858,462GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.SALK.EDUWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1960FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionBASIC RESEARCH IN THE FOLLOWING: MOLECULAR BIOLOGY & GENETICS, NEUROSCIENCE, AND PLANT BIOLOGY.ActivityOrMissionDesc
Voting Members Governing Body31VotingMembersGoverningBodyCnt
Voting Members Independent25VotingMembersIndependentCnt
Total Employee1144TotalEmployeeCnt
Total Volunteers26TotalVolunteersCnt
Total Gross UBI-$1,837,670TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$98,392NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$138,719,997PYContributionsGrantsAmt
CY Contributions Grants$150,813,576CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$18,520,658PYInvestmentIncomeAmt
CY Investment Income$21,763,570CYInvestmentIncomeAmt
PY Other Revenue$5,093,785PYOtherRevenueAmt
CY Other Revenue$1,075,216CYOtherRevenueAmt
PY Total Revenue$162,334,440PYTotalRevenueAmt
CY Total Revenue$173,652,362CYTotalRevenueAmt
PY Grants And Similar Paid$0PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$0CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$88,780,643PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$91,143,114CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$5,846,746CYTotalFundraisingExpenseAmt
PY Other Expenses$72,611,028PYOtherExpensesAmt
CY Other Expenses$76,263,720CYOtherExpensesAmt
PY Total Expenses$161,391,671PYTotalExpensesAmt
CY Total Expenses$167,406,834CYTotalExpensesAmt
PY Revenues Less Expenses$942,769PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$6,245,528CYRevenuesLessExpensesAmt
Total Assets BOY$759,827,038TotalAssetsBOYAmt
Total Assets EOY$805,255,578TotalAssetsEOYAmt
Total Liabilities BOY$144,378,095TotalLiabilitiesBOYAmt
Total Liabilities EOY$172,966,503TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$615,448,943NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$632,289,075NetAssetsOrFundBalancesEOYAmt
MissionINVOLVED IN RESEARCH ACTIVITIES, THE OBJECTIVES OF WHICH ARE THE ADVANCEMENT AND DISSEMINATION OF KNOWLEDGE RELEVANT TO THE HEALTH AND WELLBEING OF HUMANKIND. THE OBJECTIVES ARE MET PRIMARILY THROUGH RESEARCH AND ADVANCED INSTRUCTION IN (A) BIOLOGY, (B) THE CAUSE, PREVENTION AND CURE OF DISEASES, AND (C) THE FACTORS AND CIRCUMSTANCES CONDUCIVE TO THE FULFILLMENT OF HUMANKIND'S BIOLOGICAL POTENTIAL.MissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$138,470,686ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescSEE SCHEDULE ODesc
Total Program Service Expenses$138,470,686TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecYes (true)ReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsfalseGrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingYes (true)LoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document179IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee1144EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members31GoverningBodyVotingMembersCnt
Independent Voting Member25IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersYes (true)MembersOrStockholdersInd
Election Of Board MembersYes (true)ElectionOfBoardMembersInd
Decisions Subject To ApprovaYes (true)DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyfalseForm990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1KIMBERLY CASTILLOBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone8584534100PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line110010 N TORREY PINES ROADAddressLine1Txt
CityLA JOLLACityNm
State AbbreviationCAStateAbbreviationCd
ZIP920371002ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (42 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeInd
FRED GAGE PHD
PRESIDENT (OUTGOING APRIL 2023)/PROFESSOR50.0Yes (X)Yes (X)$884,422$0$53,918
GERALD JOYCE MD PHD
PRESIDENT (INCOMING APRIL 2023)/PROFESSOR50.0Yes (X)Yes (X)$451,511$0$51,587
MARNA C WHITTINGTON PHD
CHAIR2.0Yes (X)Yes (X)$0$0$0
RICHARD A HEYMAN PHD
VICE CHAIR2.0Yes (X)Yes (X)$0$0$0
ALAN D GOLD
TRUSTEE0.5Yes (X)$0$0$0
BENJAMIN H LEWIS
TRUSTEE0.5Yes (X)$0$0$0
CAROL GALLAHER PHARMD
TRUSTEE0.5Yes (X)$0$0$0
CORINNE MENTZELOPOULOS
TRUSTEE0.5Yes (X)$0$0$0
DANIEL C LEWIS
TRUSTEE0.5Yes (X)$0$0$0
DANIEL TIERNEY
TRUSTEE0.5Yes (X)$0$0$0
DAVID DOLBY
TRUSTEE0.5Yes (X)$0$0$0
DENNIS DRIVER
TRUSTEE2.0Yes (X)$0$0$0
DONALD L COHN
TRUSTEE (OUTGOING AUGUST 2022)0.5Yes (X)$0$0$0
EDWIN K HUNTER
TRUSTEE0.5Yes (X)$0$0$0
ERIC SAGERMAN
TRUSTEE2.0Yes (X)$0$0$0
FREDERICK J DOTZLER
TRUSTEE2.0Yes (X)$0$0$0
FREDERIK PAULSEN PHD
TRUSTEE0.5Yes (X)$0$0$0
HAEYOUNG KONG TANG PHD
TRUSTEE2.0Yes (X)$0$0$0
HOWARD H NEWMAN PHD
TRUSTEE0.5Yes (X)$0$0$0
IRVING WEISSMAN MD
TRUSTEE0.5Yes (X)$0$0$0
IRWIN M JACOBS SM SCD
CHAIR EMERITUS2.0Yes (X)$0$0$0
JAY FLATLEY
TRUSTEE2.0Yes (X)$0$0$0
LARRY E JENNINGS
TRUSTEE (OUTGOING AUGUST 2022)0.5Yes (X)$0$0$0
LYN HUTTON
TRUSTEE2.0Yes (X)$0$0$0
MARK KNICKREHM
TRUSTEE0.5Yes (X)$0$0$0
MARKUS REINHARD
VICE CHAIR2.0Yes (X)$0$0$0
MARTYN GOULDING PHD
TRUSTEE/PROFESSOR50.0Yes (X)$266,191$0$47,114
MARY JANE SALK
TRUSTEE0.5Yes (X)$0$0$0
REUBEN SHAW PHD
TRUSTEE/PROFESSOR50.0Yes (X)$414,745$0$48,741
SANJAY K JHA PHD
TRUSTEE0.5Yes (X)$0$0$0
TATYANA SHARPEE PHD
TRUSTEE/PROFESSOR50.0Yes (X)$255,675$0$41,957
TERRY ROSEN PHD
TRUSTEE2.0Yes (X)$0$0$0
TIMOTHY M SCHOEN
TRUSTEE2.0Yes (X)$0$0$0
WOLFGANG BUSCH PHD
TRUSTEE/PROFESSOR50.0Yes (X)$306,970$0$43,076
JULIA A MILLER JD
SECRETARY/GENERAL COUNSEL50.0Yes (X)$391,828$0$56,235
KIM E WITMER
TREASURER/SVP FINANCE & ADMN50.0Yes (X)$483,502$0$46,561
KIMBERLY CASTILLO
CHIEF FINANCIAL OFFICER50.0Yes (X)$311,772$0$51,400
DAVID LAWRENCE
EXECUTIVE DIRECTOR, HPI50.0$361,608$0$1,095Yes (X)
EDWARD CALLAWAY PHD
PROFESSOR50.0$354,745$0$52,713Yes (X)
MARTIN HETZER PHD
CSO (OUTGOING MARCH 2023)/PROFESSOR50.0$438,679$0$56,018Yes (X)
RONALD EVANS PHD
PROFESSOR50.0$427,878$0$32,096Yes (X)
SAMUEL PFAFF PHD
PROFESSOR50.0$366,432$0$55,964Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$5,715,958TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$638,475TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K147IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
EAST END ADVISORS LLC
610 FIFTH AVENUE SUITE 506NEW YORKNY10020INVESTMENT ADVISOR$2,736,484
UNIVERSITY OF CALIFORNIA SAN DIEGO
9500 GILMAN DRIVELA JOLLACA92093TRNG PROGRAM/SUBCONT$2,595,091
AO REED & CO
4777 RUFFIN STREETSAN DIEGOCA92111CONSTRUCTION SERVICE$621,177
ISEC INCORPORATED
6000 GREENWOOD PLAZA BLVD 200GREENWOOD VILLAGECO80111CONSTRUCTION SERVICE$520,000
RUDOLPH & SLETTEN INC
7584 METROPOLITAN DR STE 100SAN DIEGOCA92108CONSTRUCTION SERVICE$464,212
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K13CntrctRcvdGreaterThan100KCnt
Federated Campaigns$0FederatedCampaignsAmt
Membership Dues$0MembershipDuesAmt
Fundraising$1,034,108FundraisingAmt
Related Organizations$0RelatedOrganizationsAmt
Government Grants$75,856,260GovernmentGrantsAmt
All Other Contributions$73,923,208AllOtherContributionsAmt
Noncash Contributions$1,865,829NoncashContributionsAmt
Total Contributions$150,813,576TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

Total Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
$0$0$0
$0$0$0
$0$0$0$0
$0$0$0$0
$0$0$0$0

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,646,388TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue-$1,937,670UnrelatedBusinessRevenueAmt
Exclusion$6,584,058ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$2,075,128TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$2,075,128ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$175,422,509SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$158,305,327SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$17,117,182SecuritiesAmt
Other$0OtherAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$17,117,182TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$17,117,182ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$67,600FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$1,034,108ContriRptFundraisingEventAmt
Fundraising Direct Expenses$900,773FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$833,173TotalRevenueColumnAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion-$833,173ExclusionAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtRelated Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmtUnrelated Business RevenueUnrelatedBusinessRevenueAmtExclusionExclusionAmt
OIL ROYALTIES900099$1,781$0$0$1,781
IMAGE USE FEE900099$100,000$0$100,000$0
REVENUE SHARE-HOST VEHICLE CHARGING STAT900099$1,083$0$0$1,083

Miscellaneous Revenue MiscellaneousRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column-$269,603TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion-$269,603ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total-$166,739OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$173,652,362TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue-$1,837,670UnrelatedBusinessRevenueAmt
Exclusion$24,676,456ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$3,901,445TotalAmt
Program Services$1,737,484ProgramServicesAmt
Management And General$2,008,286ManagementAndGeneralAmt
Fundraising$155,675FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$68,660,300TotalAmt
Program Services$57,969,040ProgramServicesAmt
Management And General$7,382,225ManagementAndGeneralAmt
Fundraising$3,309,035FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$4,659,041TotalAmt
Program Services$3,827,992ProgramServicesAmt
Management And General$591,775ManagementAndGeneralAmt
Fundraising$239,274FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$8,978,297TotalAmt
Program Services$7,378,128ProgramServicesAmt
Management And General$1,140,594ManagementAndGeneralAmt
Fundraising$459,575FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$4,944,031TotalAmt
Program Services$4,062,148ProgramServicesAmt
Management And General$627,973ManagementAndGeneralAmt
Fundraising$253,910FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$245,788TotalAmt
Program Services$45,000ProgramServicesAmt
Management And General$200,788ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$1,175,992TotalAmt
Program Services$731,698ProgramServicesAmt
Management And General$444,294ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$246,005TotalAmt
Program Services$0ProgramServicesAmt
Management And General$246,005ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$3,070TotalAmt
Program Services$0ProgramServicesAmt
Management And General$3,070ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt
Fundraising$0FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$2,613,145TotalAmt
Program Services$0ProgramServicesAmt
Management And General$2,613,145ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$15,698,854TotalAmt
Program Services$13,510,928ProgramServicesAmt
Management And General$1,831,826ManagementAndGeneralAmt
Fundraising$356,100FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$25,388TotalAmt
Program Services$6,739ProgramServicesAmt
Management And General$9,958ManagementAndGeneralAmt
Fundraising$8,691FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$725,992TotalAmt
Program Services$209,809ProgramServicesAmt
Management And General$474,323ManagementAndGeneralAmt
Fundraising$41,860FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$3,780,312TotalAmt
Program Services$2,610,457ProgramServicesAmt
Management And General$869,676ManagementAndGeneralAmt
Fundraising$300,179FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$10,289,896TotalAmt
Program Services$7,850,311ProgramServicesAmt
Management And General$2,028,486ManagementAndGeneralAmt
Fundraising$411,099FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,155,870TotalAmt
Program Services$998,825ProgramServicesAmt
Management And General$103,481ManagementAndGeneralAmt
Fundraising$53,564FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$1,539,783TotalAmt
Program Services$1,094,142ProgramServicesAmt
Management And General$326,874ManagementAndGeneralAmt
Fundraising$118,767FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$304,349TotalAmt
Program Services$0ProgramServicesAmt
Management And General$304,349ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$11,692,449TotalAmt
Program Services$10,664,887ProgramServicesAmt
Management And General$930,913ManagementAndGeneralAmt
Fundraising$96,649FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$458,660TotalAmt
Program Services$0ProgramServicesAmt
Management And General$458,660ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
SCIENTIFIC SUBCONTRACTS$9,053,187$9,053,187$0$0
RESEARCH SUPPLIES$16,297,930$16,297,930$0$0
REPAIRS & PARTS$278,538$258,630$18,656$1,252
UBI TAXES$1,675$0$1,675$0

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$676,837TotalAmt
Program Services$163,351ProgramServicesAmt
Management And General$472,370ManagementAndGeneralAmt
Fundraising$41,116FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$167,406,834TotalAmt
Program Services$138,470,686ProgramServicesAmt
Management And General$23,089,402ManagementAndGeneralAmt
Fundraising$5,846,746FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$11,250,882BOYAmt
EOY$8,278,560EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$22,475,096BOYAmt
EOY$24,496,644EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$26,741,877BOYAmt
EOY$36,602,578EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$718,748BOYAmt
EOY$1,159,918EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$1,160,629BOYAmt
EOY$409,357EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$2,325,002BOYAmt
EOY$2,276,567EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$15,836BOYAmt
EOY$23,735EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$2,279,897BOYAmt
EOY$1,339,293EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$292,972,954LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$218,232,880LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$73,224,890BOYAmt
EOY$74,740,074EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$80,825,357BOYAmt
EOY$145,400,000EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$529,022,668BOYAmt
EOY$495,706,221EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$9,786,156BOYAmt
EOY$14,822,631EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$759,827,038BOYAmt
EOY$805,255,578EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$42,759,193BOYAmt
EOY$41,913,073EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$29,265,728BOYAmt
EOY$25,958,026EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$67,387,318BOYAmt
EOY$94,236,307EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$4,965,856BOYAmt
EOY$10,859,097EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$144,378,095BOYAmt
EOY$172,966,503EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$113,937,864BOYAmt
EOY$112,765,719EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$501,511,079BOYAmt
EOY$519,523,356EOYAmt

Cap Stk Tr Prin Current Funds CapStkTrPrinCurrentFundsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Pd In Cap Srpls Land Bldg Eqp Fund PdInCapSrplsLandBldgEqpFundGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rtn Earn Endowment Incm Oth Fnds RtnEarnEndowmentIncmOthFndsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$615,448,943BOYAmt
EOY$632,289,075EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$759,827,038BOYAmt
EOY$805,255,578EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$6,245,528ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$9,915,168NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets$679,436OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$166,753,206CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$160,545,802CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$176,855,692CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$138,798,417CurrentTaxYearMinus1YearAmt
Current Tax Year$150,881,176CurrentTaxYearAmt
Total$793,834,293TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$166,753,206CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$160,545,802CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$176,855,692CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$138,798,417CurrentTaxYearMinus1YearAmt
Current Tax Year$150,881,176CurrentTaxYearAmt
Total$793,834,293TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$12,425,761SubstantialContributorsTotAmt
Public Support Total170$781,408,532PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,160,349CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$4,322,033CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$6,807,160CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$9,621,065CurrentTaxYearMinus1YearAmt
Current Tax Year$6,721,516CurrentTaxYearAmt
Total$32,632,123TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$5,125CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,315CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,945CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$4,857CurrentTaxYearMinus1YearAmt
Current Tax Year$2,864CurrentTaxYearAmt
Total$18,106TotalAmt
FieldValueIRS element (for citing)
Total Support$826,484,522TotalSupportAmt
Gross Receipts Rltd Activities$0GrossReceiptsRltdActivitiesAmt
Public Support CY1700.9455PublicSupportCY170Pct
Public Support PY1700.9437PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule A, Part II, Line 10 Other IncomeFormAndLineReferenceDesc
ExplanationDESCRIPTION - OIL ROYALTIES, COLUMN A - 1545.0, COLUMN B - 1093.0, COLUMN C - 993.0, COLUMN D - 2851.0, COLUMN E - 1781.0, COLUMN F - 8263.0; DESCRIPTION - REVENUE SHARING-HOST VEHICLE CHARGING STATION, COLUMN A - 1278.0, COLUMN B - 1228.0, COLUMN C - 952.0, COLUMN D - 2006.0, COLUMN E - 1083.0, COLUMN F - 6547.0; DESCRIPTION - NET GIFT SHOP SALES, COLUMN A - 2302.0, COLUMN B - 994.0, COLUMN C - 0.0, COLUMN D - 0.0, COLUMN E - 0.0, COLUMN F - 3296.0;ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
VolunteersfalseVolunteersInd
Paid Staff Or ManagementfalsePaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsfalseDirectContactLegislatorsInd
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$3,070OtherActivitiesAmt
Total Lobbying Expenditures$3,070TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITYFormAndLineReferenceDesc
ExplanationPAID MEMBERSHIP DUES TO RESEARCH AND BIOMEDICAL ORGANIZATIONS, A PORTION OF WHICH ARE CONSIDERED LOBBYING. ASSOCIATION OF INDEPENDENT RESEARCH INSTITUTES - $1,500, NATIONAL ASSOCIATION FOR BIOMEDICAL RESEARCH - $1,200, BIOCOM - $370.ExplanationTxt

Schedule D IRS990ScheduleD

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$345,211,760BeginningYearBalanceAmt
Contributions$4,585,120ContributionsAmt
Investment Earnings Or Losses$17,999,745InvestmentEarningsOrLossesAmt
Other Expenditures$16,695,002OtherExpendituresAmt
End Year Balance$351,101,623EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$375,050,161BeginningYearBalanceAmt
Contributions$1,603,261ContributionsAmt
Investment Earnings Or Losses-$15,394,543InvestmentEarningsOrLossesAmt
Other Expenditures$16,047,119OtherExpendituresAmt
End Year Balance$345,211,760EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$299,166,085BeginningYearBalanceAmt
Contributions$14,926,831ContributionsAmt
Investment Earnings Or Losses$74,973,285InvestmentEarningsOrLossesAmt
Other Expenditures$14,016,040OtherExpendituresAmt
End Year Balance$375,050,161EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$286,834,762BeginningYearBalanceAmt
Contributions$6,580,341ContributionsAmt
Investment Earnings Or Losses$17,530,495InvestmentEarningsOrLossesAmt
Other Expenditures$11,779,513OtherExpendituresAmt
End Year Balance$299,166,085EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$240,056,992BeginningYearBalanceAmt
Contributions$42,422,494ContributionsAmt
Investment Earnings Or Losses$14,937,417InvestmentEarningsOrLossesAmt
Other Expenditures$10,582,141OtherExpendituresAmt
End Year Balance$286,834,762EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.0311BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.728PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.2409TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd

Land LandGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,153,930OtherCostOrOtherBasisAmt
Book Value$1,153,930BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$64,209,980OtherCostOrOtherBasisAmt
Depreciation$54,562,927DepreciationAmt
Book Value$9,647,053BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$102,610,267OtherCostOrOtherBasisAmt
Depreciation$73,412,189DepreciationAmt
Book Value$29,198,078BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$123,700,198OtherCostOrOtherBasisAmt
Depreciation$88,973,442DepreciationAmt
Book Value$34,726,756BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,298,579OtherCostOrOtherBasisAmt
Depreciation$1,284,322DepreciationAmt
Book Value$14,257BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$74,740,074TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (3 entries)

DescDescBook ValueBookValueAmtMethod ValuationMethodValuationCd
ALTERNATIVE INVESTMENTS$466,747,759F
STOCKS NOT-PUBLICLY TRADED <5%$3,011C
LIMITED PARTNERSHIP INTEREST$28,955,451F
FieldValueIRS element (for citing)
Total Book Value Securities$495,706,221TotalBookValueSecuritiesAmt
Federal Income Tax Liability$5,143FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
DEFERRED RETIREE MEDICAL OBLIG$4,174,113
LEASE LIABILITY$6,679,841
FieldValueIRS element (for citing)
Total Liability$10,859,097TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$178,205,447TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$9,915,168NetUnrealizedGainsInvstAmt
Other Revenue-$3,705,857OtherRevenueAmt
Revenue Not Reported$6,209,311RevenueNotReportedAmt
Revenue Subtotal$171,996,136RevenueSubtotalAmt
Investment Expenses Not Incld$2,556,446InvestmentExpensesNotIncldAmt
Other Revenues Not Included-$900,220OtherRevenuesNotIncludedAmt
Revenue Not Reported Fincl Stmt$1,656,226RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990$173,652,362TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$165,750,610TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included$900,773OtherExpensesIncludedAmt
Expenses Not Reported$900,773ExpensesNotReportedAmt
Expenses Subtotal$164,849,837ExpensesSubtotalAmt
Investment Expenses Not Incld2$2,556,446InvestmentExpensesNotIncld2Amt
Other Expenses Not Included$551OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt$2,556,997ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990$167,406,834TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule D, Part XI, Line 2(d)INVESTMENT RETURN IN EXCESS OF AMOUNT DESIGNATED FOR CURRENT OPERATIONS UNDER SPENDING POLICY ($3,659,268), CHANGE IN VALUE OF DEFERRED GIFTS ($46,590), AND ROUNDING $1.
Schedule D, Part XI, Line 4(b)FUNDRAISING EXPENSES ($900,773) AND ROUNDING $553
Schedule D, Part XII, Line 2(d)FUNDRAISING EVENTS EXPENSE $900,773 AND ROUNDING $552
Schedule D, Part V, Line 4 Intended uses of endowment fundsENDOWMENT INCOME INTENDED TO BE USED FOR AND TO SUPPORT RESEARCH, OPERATIONS, AND LECTURESHIP EXPENSES.
Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnoteINCOME TAXES - THE INSTITUTE HAS NO UNRECOGNIZED TAX BENEFITS AS OF JUNE 30, 2023 AND 2022.
Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990INVESTMENT RETURN IN EXCESS OF AMOUNT DESIGNATED FOR CURRENT OPERATIONS UNDER SPENDING POLICY - -3659268 CHANGE IN VALUE OF DEFERRED GIFTS - -46590 ROUNDING - 1
Schedule D, Part XI, Line 4(b) Other revenues in form 990 not in audited financial statementsFUNDRAISING EXPENSES - -900773 ROUNDING - 553
Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990FUNDRAISING EXPENSES - 900773
Schedule D, Part XII, Line 4(b) Other expenses in form 990 not in audited financial statementsROUNDING - 551

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (11 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)00Program ServicesSCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION.$172,584
North America (Canada & Mexico only)00Program ServicesSCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION.$74,790
Central America and the Caribbean00Program ServicesSCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION.$5,937
East Asia and the Pacific00Program ServicesSCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION.$50,495
Middle East and North Africa00Program ServicesSCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION.$2,984
South America00Program ServicesSCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION.$9,101
Russia and Neighboring States00Program ServicesSCIENTISTS TRAVEL TO FOREIGN COUNTRIES TO ATTEND CONFERENCES. WE DO NOT DEEM THESE ACTIVITIES TO CONSTITUTE WORKING IN THE REGION.$1,133
Central America and the Caribbean00Investments$210,145,003
Europe (Including Iceland and Greenland)00Investments$23,265,027
Sub-Saharan Africa00Investments$372,470
North America (Canada & Mexico only)00Investments$1,215,756
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$235,315,280SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$235,315,280TotalSpentAmt
Transfer To Foreign CorpYes (true)TransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipYes (true)ForeignCorpOwnershipInd
Passive Foreign Investmest CoYes (true)PassiveForeignInvestmestCoInd
Foreign PartnershipYes (true)ForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 3 Method used to account for expenditures on org's financial statementsFormAndLineReferenceDesc
ExplanationCENTRAL AMERICA AND THE CARIBBEAN-Accrual; EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; MIDDLE EAST AND NORTH AFRICA-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual; RUSSIA AND NEIGHBORING STATES-Accrual; SOUTH AMERICA-Accrual; SUB-SAHARAN AFRICA-AccrualExplanationTxt

Schedule G IRS990ScheduleG

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1CONCERTEvent1Nm
Gross Receipts Event1$1,101,708GrossReceiptsEvent1Amt
Charitable Contri Event1$1,034,108CharitableContriEvent1Amt
Gross Revenue Event1$67,600GrossRevenueEvent1Amt
Food And Beverage Event1$87,653FoodAndBeverageEvent1Amt
Entertainment Event1$412,589EntertainmentEvent1Amt
Other Direct Expenses Event1$400,531OtherDirectExpensesEvent1Amt
Gross Revenue Event2$0GrossRevenueEvent2Amt
Other Events Total0OtherEventsTotalCnt
Gross Revenue Other Events$0GrossRevenueOtherEventsAmt
Gross Receipts Total$1,101,708GrossReceiptsTotalAmt
Charitable Contributions Tot$1,034,108CharitableContributionsTotAmt
Gross Revenue Total Events$67,600GrossRevenueTotalEventsAmt
Food And Beverage Total Events$87,653FoodAndBeverageTotalEventsAmt
Entertainment Total Events$412,589EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$400,531OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$900,773DirectExpenseSummaryEventsAmt
Net Income Summary-$833,173NetIncomeSummaryAmt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E ExpnssYes (true)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (true)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
FRED GAGE PHD
PRESIDENT (OUTGOING APRIL 2023)/PROFESSOR$867,507$0$0$0$16,915$0$36,600$0$17,318$0$938,340$0$0$0
GERALD JOYCE MD PHD
PRESIDENT (INCOMING APRIL 2023)/PROFESSOR$441,224$0$0$0$10,287$0$36,600$0$14,987$0$503,098$0$0$0
REUBEN SHAW PHD
TRUSTEE/PROFESSOR$250,741$0$0$0$164,004$0$36,600$0$12,141$0$463,486$0$0$0
MARTYN GOULDING PHD
TRUSTEE/PROFESSOR$246,178$0$0$0$20,013$0$32,622$0$14,492$0$313,305$0$0$0
TATYANA SHARPEE PHD
TRUSTEE/PROFESSOR$226,204$0$0$0$29,471$0$29,958$0$11,999$0$297,632$0$0$0
WOLFGANG BUSCH PHD
TRUSTEE/PROFESSOR$215,033$0$0$0$91,937$0$32,744$0$10,332$0$350,046$0$0$0
KIM E WITMER
TREASURER/SVP FINANCE & ADMN$466,254$0$0$0$17,248$0$36,600$0$9,961$0$530,063$0$0$0
JULIA A MILLER JD
SECRETARY/GENERAL COUNSEL$373,036$0$0$0$18,792$0$36,600$0$19,635$0$448,063$0$0$0
KIMBERLY CASTILLO
CHIEF FINANCIAL OFFICER$302,168$0$0$0$9,604$0$36,600$0$14,800$0$363,172$0$0$0
MARTIN HETZER PHD
CSO (OUTGOING MARCH 2023)/PROFESSOR$404,256$0$0$0$34,423$0$36,600$0$19,418$0$494,697$0$0$0
RONALD EVANS PHD
PROFESSOR$392,063$0$0$0$35,815$0$30,500$0$1,596$0$459,974$0$0$0
SAMUEL PFAFF PHD
PROFESSOR$294,058$0$0$0$72,374$0$36,600$0$19,364$0$422,396$0$0$0
DAVID LAWRENCE
EXECUTIVE DIRECTOR, HPI$355,385$0$0$0$6,223$0$1,095$0$0$0$362,703$0$0$0
EDWARD CALLAWAY PHD
PROFESSOR$343,386$0$0$0$11,359$0$36,600$0$16,113$0$407,458$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule J, Part I, Line 1a First-class or charter travelFormAndLineReferenceDesc
ExplanationFIRST-CLASS OR CHARTER TRAVEL: FRED GAGE, PRESIDENT/PROFESSOR - $22,315; GERALD JOYCE, PRESIDENT/PROFESSOR - $2,869; KIM WITMER, SVP-FINANCE & ADMINISTRATION - $858; MARTIN HETZER. CSO/PROFESSOR - $394. NOT TAXABLE - ACCOUNTABLE PLAN.ExplanationTxt

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (3 entries)

Relationship With OrgRelationshipWithOrgTxtLoan PurposeLoanPurposeTxtLoan From OrganizationLoanFromOrganizationIndOriginal PrincipalOriginalPrincipalAmtBalance DueBalanceDueAmtDefaultDefaultIndBoard Or Committee ApprovalBoardOrCommitteeApprovalIndWritten AgreementWrittenAgreementInd
REUBEN SHAW
PROFESSORHOME LOANYes (X)$700,000$337,550falseYes (true)Yes (true)
TATYANA SHARPEE
PROFESSORHOME LOANYes (X)$30,140$30,140falseYes (true)Yes (true)
WOLFGANG BUSCH
PROFESSORHOME LOANYes (X)$250,000$41,667falseYes (true)Yes (true)
FieldValueIRS element (for citing)
Total Balance Due$409,357TotalBalanceDueAmt

Schedule M IRS990ScheduleM

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution118ContributionCnt
Noncash Contributions Rpt F990$1,865,829NoncashContributionsRptF990Amt
Method Of Determining RevenuesMarket valueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I Explanations of reporting method for number of contributionsFormAndLineReferenceDesc
ExplanationSecurities - Publicly traded - THE AMOUNT REPORTED REPRESENTS THE NUMBER OF CONTRIBUTIONS RECEIVED.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (15 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part III, Line 4a continued1IMAGING REVEALS HOW LARGE HIV PROTEIN FUNCTIONS TO FORM INFECTIOUS VIRUS - UNDERSTANDING HOW HIV REPLICATES WITHIN CELLS IS KEY FOR DEVELOPING NEW THERAPIES FOR THE NEARLY 40 MILLION PEOPLE LIVING WITH HIV GLOBALLY. A TEAM OF SCIENTISTS FROM THE SALK INSTITUTE AND RUTGERS UNIVERSITY HAVE DETERMINED THE MOLECULAR STRUCTURE OF HIV POL, A PROTEIN THAT PLAYS A KEY ROLE IN THE LATE STAGES OF HIV REPLICATION, OR THE PROCESS THROUGH WHICH THE VIRUS PROPAGATES ITSELF AND SPREADS THROUGH THE BODY. DETERMINING THE MOLECULE'S STRUCTURE HELPS ANSWER LONGSTANDING QUESTIONS ABOUT HOW THE PROTEIN BREAKS ITSELF APART TO ADVANCE THE REPLICATION PROCESS. THE DISCOVERY REVEALS A NEW VULNERABILITY IN THE VIRUS THAT COULD BE TARGETED WITH DRUGS. THE STUDY WAS LED BY ASSISTANT PROFESSOR DMITRY LYUMKIS AND PUBLISHED IN SCIENCE ADVANCES ON JULY 6, 2022. THE BEST OFFENSE IS A GREAT DEFENSE FOR SOME CARNIVOROUS PLANTS - INSECT-EATING PLANTS HAVE FASCINATED BIOLOGISTS FOR MORE THAN A CENTURY, BUT HOW PLANTS EVOLVED THE ABILITY TO CAPTURE AND CONSUME LIVE PREY HAS LARGELY REMAINED A MYSTERY. NOW, SALK SCIENTISTS, ALONG WITH COLLABORATORS FROM WASHINGTON UNIVERSITY IN ST. LOUIS, HAVE INVESTIGATED THE MOLECULAR BASIS OF PLANT CARNIVORY AND FOUND EVIDENCE THAT IT EVOLVED FROM MECHANISMS PLANTS USE TO DEFEND THEMSELVES. THE RESEARCH DETAILS HOW CALCIUM MOLECULES MOVE DYNAMICALLY WITHIN CELLS IN THE LEAVES OF CARNIVOROUS PLANTS IN RESPONSE TO TOUCH FROM LIVE PREY. THE STUDY WAS LED BY PROFESSOR JOANNE CHORY AND PUBLISHED IN PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES ON JULY 11, 2022. HOW RNA PROCESSING GOES AWRY IN RARE IMMUNE DISEASE - RESEARCHERS AT THE SALK INSTITUTE AND KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (KAUST) IN SAUDI ARABIA DISCOVERED A NEW UNDERLYING CAUSE OF WISKOTT-ALDRICH SYNDROME, A RARE GENETIC DISEASE THAT LEADS TO BLEEDING AND IMMUNE DEFICIENCIES IN BABIES. THEY FOUND THE GENETIC MUTATIONS ASSOCIATED WITH WISKOTT-ALDRICH SYNDROME DISRUPT RNA SPLICING WHICH, IN TURN, PREVENTS NUMEROUS IMMUNE AND ANTI-INFLAMMATORY PROTEINS FROM BEING MADE CORRECTLY. THE STUDY WAS LED BY PROFESSOR JUAN CARLOS IZPISUA BELMONTE AND PUBLISHED IN NATURE COMMUNICATIONS ON JUNE 25, 2022. MAKING A MEMORY POSITIVE OR NEGATIVE - RESEARCHERS AT THE SALK INSTITUTE AND COLLEAGUES DISCOVERED THE MOLECULE IN THE BRAIN RESPONSIBLE FOR ASSOCIATING GOOD OR BAD FEELINGS WITH A MEMORY. THEIR DISCOVERY PAVES THE WAY FOR A BETTER UNDERSTANDING OF WHY SOME PEOPLE ARE MORE LIKELY TO RETAIN NEGATIVE EMOTIONS THAN POSITIVE ONES-AS CAN OCCUR WITH ANXIETY, DEPRESSION OR POST-TRAUMATIC STRESS DISORDER (PTSD). THE STUDY WAS LED BY PROFESSOR KAY TYE AND PUBLISHED IN NATURE ON JULY 20, 2022. A SURPRISING LINK BETWEEN MITOCHONDRIAL DNA AND INCREASED ATHEROSCLEROSIS RISK - MITOCHONDRIA ARE KNOWN AS CELLS' POWERHOUSES, BUT MOUNTING EVIDENCE SUGGESTS THEY ALSO PLAY A ROLE IN INFLAMMATION. SCIENTISTS FROM THE SALK INSTITUTE AND UC SAN DIEGO EXAMINED HUMAN BLOOD CELLS AND DISCOVERED A SURPRISING LINK BETWEEN MITOCHONDRIA, INFLAMMATION AND DNMT3A AND TET2-TWO GENES THAT NORMALLY HELP REGULATE BLOOD CELL GROWTH BUT, WHEN MUTATED, ARE ASSOCIATED WITH AN INCREASED RISK OF ARTERY-BLOCKING PLAQUE BUILDUP KNOWN AS ATHEROSCLEROSIS. THE FINDINGS COULD LEAD TO NEW THERAPEUTICS FOR ATHEROSCLEROSIS AND OTHER INFLAMMATORY DISEASES. THE STUDY WAS LED BY PROFESSOR GERALD SHADEL AND PUBLISHED IN IMMUNITY ON AUGUST 2, 2022. DISCOVERY ADVANCES THE POTENTIAL OF GENE THERAPY TO RESTORE HEARING LOSS - RESEARCH FROM THE SALK INSTITUTE AND THE UNIVERSITY OF SHEFFIELD MAY DRIVE THE DEVELOPMENT OF NEW GENE THERAPIES TO REPAIR HEARING LOSS. IN DEVELOPED COUNTRIES, ROUGHLY 80 PERCENT OF DEAFNESS CASES THAT OCCUR BEFORE A CHILD LEARNS TO SPEAK ARE DUE TO GENETIC FACTORS. ONE OF THESE GENETIC COMPONENTS LEADS TO THE ABSENCE OF THE PROTEIN EPS8, WHICH COINCIDES WITH IMPROPER DEVELOPMENT OF SENSORY HAIR CELLS IN THE INNER EAR. THE TEAM'S FINDINGS SHOW THAT DELIVERY OF NORMAL EPS8 CAN RESCUE STEREOCILIA ELONGATION AND THE FUNCTION OF AUDITORY HAIR CELLS IN THE EARS OF MICE AFFECTED BY THE LOSS OF EPS8. THE STUDY WAS LED BY ASSISTANT PROFESSOR URI MANOR AND PUBLISHED IN MOLECULAR THERAPY - METHODS & CLINICAL DEVELOPMENT ON JULY 31, 2022. NEW TARGET IDENTIFIED FOR TREATMENT OF PREMATURE AGING DISEASE - SCIENTISTS AT THE SALK INSTITUTE AND KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (KAUST) IN SAUDI ARABIA DISCOVERED THAT A STRETCH OF DNA THAT HOPS AROUND THE HUMAN GENOME PLAYS A ROLE IN PREMATURE AGING DISORDERS. IN PEOPLE WITH EARLY AGING, OR PROGERIA, RNA ENCODED BY THIS MOBILE DNA BUILDS UP INSIDE CELLS. THE SCIENTISTS ALSO FOUND THAT BLOCKING THIS RNA REVERSES THE DISEASE IN MICE. THE STUDY WAS LED BY PROFESSOR JUAN CARLOS IZPISUA BELMONTE AND PUBLISHED IN SCIENCE TRANSLATIONAL MEDICINE ON AUGUST 10, 2022. HOW THE BRAIN GATHERS THREAT CUES AND TURNS THEM INTO FEAR - SCIENTISTS AT THE SALK INSTITUTE UNCOVERED A MOLECULAR PATHWAY THAT DISTILLS THREATENING SIGHTS, SOUNDS AND SMELLS INTO A SINGLE MESSAGE: BE AFRAID. A MOLECULE CALLED CGRP ENABLES NEURONS IN TWO SEPARATE AREAS OF THE BRAIN TO BUNDLE THREATENING SENSORY CUES INTO A UNIFIED SIGNAL, TAG IT AS NEGATIVE AND CONVEY IT TO THE AMYGDALA, WHICH TRANSLATES THE SIGNAL INTO FEAR. THE RESEARCH MAY LEAD TO NEW THERAPIES FOR FEAR-RELATED DISORDERS SUCH AS POST-TRAUMATIC STRESS DISORDER (PTSD) OR HYPERSENSITIVITY DISORDERS SUCH AS AUTISM, MIGRAINES AND FIBROMYALGIA. THE STUDY WAS LED BY ASSISTANT PROFESSOR SUNG HAN AND PUBLISHED IN CELL REPORTS ON AUGUST 16, 2022. HOW LIGHT AND TEMPERATURE WORK TOGETHER TO AFFECT PLANT GROWTH - PLANTS LENGTHEN AND BEND TO SECURE ACCESS TO SUNLIGHT. DESPITE OBSERVING THIS PHENOMENON FOR CENTURIES, SCIENTISTS DO NOT FULLY UNDERSTAND IT. SALK SCIENTISTS DISCOVERED THAT TWO PLANT FACTORS-THE PROTEIN PIF7 AND THE GROWTH HORMONE AUXIN-ARE THE TRIGGERS THAT ACCELERATE GROWTH WHEN PLANTS ARE SHADED BY CANOPY AND EXPOSED TO WARM TEMPERATURES AT THE SAME TIME. THE FINDINGS WILL HELP SCIENTISTS INCREASE CROP PRODUCTIVITY DESPITE RISING GLOBAL TEMPERATURES. THE STUDY WAS LED BY PROFESSOR JOANNE CHORY AND PUBLISHED IN NATURE COMMUNICATIONS ON AUGUST 29, 2022. BEYOND NEURONS: HOW CELLS CALLED ASTROCYTES CONTRIBUTE TO BRAIN DISORDERS - MOST RESEARCH ON BRAIN DISEASES FOCUSES ON NEURONS, BUT STAR-SHAPED CELLS CALLED ASTROCYTES, ANOTHER ABUNDANT CELL IN THE HUMAN BRAIN, MAY BEAR THE BRUNT OF THE RESPONSIBILITY IN SOME NEURODEVELOPMENTAL DISORDERS. SALK INSTITUTE SCIENTISTS IDENTIFIED A MOLECULE PRODUCED BY ASTROCYTES THAT INTERFERES WITH NORMAL NEURON DEVELOPMENT IN RETT, FRAGILE X AND DOWN SYNDROMES, AND REPORT THAT BLOCKING THE MOLECULE REDUCES THE SIGNS OF DISEASE IN MICE BRAINS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR NICOLA ALLEN AND PUBLISHED IN NATURE NEUROSCIENCE ON AUGUST 30, 2022. AGGRESSION DE-ESCALATION GENE IDENTIFIED IN FRUIT FLIES - THE BRAIN MECHANISMS THAT CAUSE AGGRESSIVE BEHAVIOR HAVE BEEN WELL STUDIED, BTU FAR LESS IS KNOWN ABOUT THE PROCESSES THAT TELL THE BODY WHEN IT'S TIME TO STOP FIGHTING. SALK INSTITUTE SCIENTISTS IDENTIFIED A GENE AND A GROUP OF CELLS IN THE BRAIN THAT PLAY A CRITICAL ROLE IN SUPPRESSING AGGRESSION IN FRUIT FLIES. THE FINDINGS HAVE IMPLICATIONS FOR DISORDERS SUCH AS PARKINSON'S DISEASE, WHICH CAN SOMETIMES CAUSE BEHAVIORAL CHANGES LIKE INCREASED AGGRESSION AND COMBATIVENESS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR KENTA ASAHINA AND PUBLISHED IN SCIENCE ADVANCES ON SEPTEMBER 7, 2022. TIME-RESTRICTED EATING IMPROVES HEALTH OF FIREFIGHTERS - FIREFIGHTER'S 24-HOUR SHIFTS ARE HARD ON THE BODY AND INCREASE THE RISK OF CARDIOMETABOLIC DISEASES, SUCH AS HEART DISEASE AND DIABETES, AS WELL AS CANCER. IN COLLABORATION WITH THE SAN DIEGO FIRE-RESCUE DEPARTMENT, SCIENTISTS FROM THE SALK INSTITUTE AND UC SAN DIEGO HEALTH CONDUCTED A CLINICAL TRIAL AND FOUND THAT TIME-RESTRICTED EATING IMPROVED MEASURES OF HEALTH AND WELLBEING IN FIREFIGHTERS. THE NEW FINDINGS MAY ALSO HAVE IMPLICATIONS FOR SHIFT WORKERS, SUCH AS MILITARY PERSONNEL; HEALTH CARE, FOOD SERVICE, AND TRANSPORTATION PROFESSIONALS; TELECOMMUNICATIONS STAFF; AND NEW PARENTS, WHOSE SCHEDULES OFTEN MIMIC SHIFT WORK WHEN CARING FOR A NEW BABY. THE STUDY WAS LED BY PROFESSOR SATCHIDANANDA PANDA AND PUBLISHED IN CELL METABOLISM ON OCTOBER 4, 2022.
Form 990, Part III, Line 4a continued2GROWING MOTOR NEURONS GUIDED BY "LOVE-HATE RELATIONSHIP" WITH BLOOD VESSELS - WHEN NEURONS INVOLVED IN MOVEMENT-CALLED MOTOR NEURONS-FORM, THEY MUST BUILD CONNECTIONS THAT REACH FROM THE BRAIN, BRAINSTEM, OR SPINAL CORD ALL THE WAY TO THE HEAD, ARMS, OR THE TIPS OF THE TOES. A COLLABORATIVE STUDY BETWEEN SALK INSTITUTE SCIENTISTS AND COLLEAGUES AT THE SAN RAFFAELE SCIENTIFIC INSTITUTE IN ITALY SHOWED HOW BLOOD VESSEL GENES PLAY A CRITICAL ROLE IN MOTOR NEURON DEVELOPMENT BY TELLING BLOOD VESSELS TO GET OUT OF THE WAY. THE DISCOVERY HAS IMPLICATIONS FOR UNDERSTANDING DISEASES IN WHICH MOTOR NEURON CONNECTIONS ARE DESTROYED, SUCH AS AMYOTROPHIC LATERAL SCLEROSIS (ALS) OR SPINAL MUSCULAR ATROPHY (SMA). THE STUDY WAS LED BY PROFESSOR SAMUEL PFAFF AND PUBLISHED IN NEURON ON OCTOBER 7, 2022. ANTI-INFLAMMATORY MOLECULES DECLINE IN THE AGING BRAIN - AGING INVOLVES INFLAMMATION, STRESS, METABOLISM CHANGES, AND MORE. A TEAM OF SALK INSTITUTE AND UC SAN DIEGO SCIENTISTS REVEALED ANOTHER FACTOR IMPLICATED IN THE AGING PROCESS-A CLASS OF LIPIDS CALLED SGDGS (3-SULFOGALACTOSYL DIACYLGLYCEROLS) THAT DECLINE IN THE BRAIN WITH AGE AND MAY HAVE ANTI-INFLAMMATORY EFFECTS. THE RESEARCH HELPS UNRAVEL THE MOLECULAR BASIS OF BRAIN AGING, REVEALS NEW MECHANISMS UNDERLYING AGE-RELATED NEUROLOGICAL DISEASES, AND OFFERS FUTURE OPPORTUNITIES FOR THERAPEUTIC INTERVENTION. THE STUDY WAS LED BY PROFESSOR ALAN SAGHATELIAN AND PUBLISHED IN NATURE CHEMICAL BIOLOGY ON OCTOBER 20, 2022. DETERIORATING NEURONS ARE SOURCE OF BRAIN INFLAMMATION IN ALZHEIMER'S DISEASE - SCIENTISTS FROM THE SALK INSTITUTE FOUND THAT NEURONS FROM PEOPLE WITH ALZHEIMER'S DISEASE SHOW DETERIORATION AND UNDERGO A LATE-LIFE STRESS PROCESS CALLED SENESCENCE. THESE NEURONS HAVE A LOSS OF FUNCTIONAL ACTIVITY, IMPAIRED METABOLISM, AND INCREASED BRAIN INFLAMMATION. THE RESEARCHERS ALSO DISCOVERED THAT TARGETING THE DETERIORATING NEURONS WITH THERAPEUTICS COULD BE AN EFFECTIVE STRATEGY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE. THE STUDY WAS LED BY PROFESSOR RUSTY GAGE AND PUBLISHED IN CELL STEM CELL ON DECEMBER 1, 2022. FLIPPING THE SWITCH: GENETIC CHANGES THAT TURN "ON" CANCER GENES - CANCER CAN BE CAUSED BY GENETIC MUTATIONS, YET THE IMPACT OF SPECIFIC TYPES SUCH AS STRUCTURAL VARIANTS THAT BREAK AND REJOIN DNA, CAN VARY WIDELY. RESEARCHERS FROM THE SALK INSTITUTE ZEROED IN ON SPECIFIC MECHANISMS THAT ACTIVATE ONCOGENES, SHOWING THAT THE ACTIVITY OF CANCER-ASSOCIATED MUTATIONS DEPENDS ON THE DISTANCE BETWEEN A PARTICULAR GENE AND THE SEQUENCES THAT REGULATE THE GENE, AS WELL AS ON THE LEVEL OF ACTIVITY OF THE REGULATORY SEQUENCES INVOLVED. THIS WORK ADVANCES THE ABILITY TO PREDICT AND INTERPRET WHICH GENETIC MUTATIONS FOUND IN CANCER GENOMES ARE CAUSING THE DISEASE. THE STUDY WAS LED BY ASSISTANT PROFESSOR JESSE DIXON AND PUBLISHED IN NATURE ON DECEMBER 7, 2022. NEW COMPOUND REVERSES GUT INFLAMMATION IN MICE - A DRUG DEVELOPED BY SALK INSTITUTE RESEARCHERS ACTS LIKE A MASTER RESET SWITCH IN THE INTESTINES. THE COMPOUND, CALLED FEXD, HAS PREVIOUSLY BEEN FOUND TO LOWER CHOLESTEROL, BURN FAT, AND WARD OFF COLORECTAL CANCER IN MICE. NOW, THE TEAM REPORTED THAT FEXD CAN ALSO PREVENT AND REVERSE INTESTINAL INFLAMMATION IN MOUSE MODELS OF INFLAMMATORY BOWEL DISEASE. THE STUDY WAS LED BY PROFESSOR RONALD EVANS AND PUBLISHED IN PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES ON DECEMBER 12, 2022. THE BRAIN'S ABILITY TO PERCEIVE SPACE EXPANDS LIKE THE UNIVERSE - SALK SCIENTISTS DISCOVERED THAT TIME SPENT EXPLORING AN ENVIRONMENT CAUSES NEURAL REPRESENTATIONS TO GROW IN SURPRISING WAYS. THEIR FINDINGS SHOW THAT NEURONS IN THE HIPPOCAMPUS ESSENTIAL FOR SPATIAL NAVIGATION, MEMORY, AND PLANNING REPRESENT SPACE IN A MANNER THAT CONFORMS TO A NONLINEAR HYPERBOLIC GEOMETRY-A THREE-DIMENSIONAL EXPANSE THAT GROWS OUTWARD EXPONENTIALLY. IN OTHER WORDS, IT'S SHAPED LIKE THE INTERIOR OF AN EXPANDING HOURGLASS. THE RESEARCHERS ALSO FOUND THAT THE SIZE OF THAT SPACE GROWS WITH TIME SPENT IN A PLACE. THIS DISCOVERY PROVIDES VALUABLE METHODS FOR ANALYZING DATA ON NEUROCOGNITIVE DISORDERS INVOLVING LEARNING AND MEMORY, SUCH AS ALZHEIMER'S DISEASE. THE STUDY WAS LED BY PROFESSOR TATYANA SHARPEE AND PUBLISHED IN NATURE NEUROSCIENCE ON DECEMBER 29, 2022. MICROPROTEIN INCREASES APPETITE IN MICE - OBESITY AND METABOLIC DISEASES, SUCH AS DIABETES, ARE EXTREMELY COMMON IN THE UNITED STATES. TINY PROTEINS CALLED MICROPROTEINS HAVE LONG BEEN OVERLOOKED IN RESEARCH, BUT NEW EVIDENCE DEMONSTRATES THAT THEY HAVE AN IMPORTANT ROLE IN METABOLISM. SALK INSTITUTE SCIENTISTS DISCOVERED THAT BOTH BROWN AND WHITE FAT IS FILLED WITH THOUSANDS OF PREVIOUSLY UNKNOWN MICROPROTEINS, AND SHOWED THAT ONE OF THESE MICROPROTEINS, CALLED GM8773, CAN INCREASE APPETITE IN MICE. THESE FINDINGS COULD LEAD TO THE DEVELOPMENT OF A THERAPEUTIC TO HELP PEOPLE GAIN WEIGHT IN CERTAIN DISEASE SITUATIONS, SUCH AS DURING CHEMOTHERAPY FOR CANCER. THE STUDY WAS LED BY PROFESSOR ALAN SAGHATELIAN AND PUBLISHED IN CELL METABOLISM ON JANUARY 3, 2023. TIME-RESTRICTED EATING RESHAPES GENE EXPRESSION THROUGHOUT THE BODY - EXACTLY HOW TIME-RESTRICTED FEEDING AFFECTS THE BODY ON THE MOLECULAR LEVEL, AND HOW THOSE CHANGES INTERACT ACROSS MULTIPLE ORGAN SYSTEMS, HAS NOT BEEN WELL UNDERSTOOD. SCIENTISTS AT THE SALK INSTITUTE SHOWED HOW TIME-RESTRICTED EATING INFLUENCES GENE EXPRESSION IN MICE ACROSS MORE THAN 22 REGIONS OF THE BODY AND BRAIN. THE FINDINGS HAVE IMPLICATIONS FOR A WIDE RANGE OF HEALTH CONDITIONS WHERE TIME-RESTRICTED EATING HAS SHOWN POTENTIAL BENEFITS, INCLUDING DIABETES, HEART DISEASE, HYPERTENSION, AND CANCER. THE STUDY WAS LED BY PROFESSOR SATCHIDANANDA PANDA AND PUBLISHED IN CELL METABOLISM ON JANUARY 3, 2023. SUPPLEMENTATION WITH AMINO ACID SERINE EASES NEUROPATHY IN DIABETIC MICE - APPROXIMATELY HALF OF PEOPLE WITH TYPE 1 OR TYPE 2 DIABETES EXPERIENCE PERIPHERAL NEUROPATHY-WEAKNESS, NUMBNESS, AND PAIN, PRIMARILY IN THE HANDS AND FEET. SALK INSTITUTE RESEARCHERS IDENTIFIED A NEW FACTOR CONTRIBUTING TO DIABETES-ASSOCIATED PERIPHERAL NEUROPATHY: ALTERED AMINO ACID METABOLISM. THE TEAM FOUND THAT DIABETIC MICE WITH LOW LEVELS OF TWO RELATED AMINO ACIDS, SERINE AND GLYCINE, ARE AT HIGHER RISK FOR PERIPHERAL NEUROPATHY. THEY WERE ALSO ABLE TO ALLEVIATE NEUROPATHY SYMPTOMS IN DIABETIC MICE BY SUPPLEMENTING THEIR DIETS WITH SERINE. THE STUDY WAS LED BY PROFESSOR CHRISTIAN METALLO AND PUBLISHED IN NATURE ON JANUARY 25, 2023. TELOMERES, MITOCHONDRIA, AND INFLAMMATION WORK TOGETHER TO PREVENT CANCER - A TEAM OF SALK SCIENTISTS DISCOVERED THAT WHEN TELOMERES, THE END CAPS OF OUR CHROMOSOMES, BECOME VERY SHORT, THEY COMMUNICATE WITH MITOCHONDRIA, THE CELL'S POWERHOUSES. THIS COMMUNICATION TRIGGERS A COMPLEX SET OF SIGNALING PATHWAYS AND INITIATES AN INFLAMMATORY RESPONSE THAT DESTROYS CELLS THAT COULD OTHERWISE BECOME CANCEROUS. THE FINDINGS OPEN NEW POSSIBILITIES FOR PREVENTING AND TREATING CANCER AND OTHER HARMFUL CONSEQUENCES OF AGING. THE STUDY WAS LED BY PROFESSORS JAN KARLSEDER AND GERALD SHADEL AND PUBLISHED IN NATURE ON FEBRUARY 8, 2023. AI CHATBOT CHATGPT MIRRORS ITS USERS TO APPEAR INTELLIGENT - THE ARTIFICIAL INTELLIGENCE (AI) LANGUAGE MODEL CHATGPT MAY HAVE MANY APPLICATIONS IN SCIENCE AND BUSINESS, BUT HOW MUCH DO THESE TOOLS UNDERSTAND WHAT WE SAY TO THEM AND HOW DO THEY DECIDE WHAT TO SAY BACK? SALK INSTITUTE SCIENTISTS EXPLORED THE RELATIONSHIP BETWEEN THE HUMAN INTERVIEWER AND LANGUAGE MODELS TO UNCOVER WHY CHATBOTS RESPOND IN PARTICULAR WAYS, WHY THOSE RESPONSES VARY, AND HOW TO IMPROVE THEM IN THE FUTURE. THE RESULTS SUGGEST THAT LANGUAGE MODELS REFLECT THE INTELLIGENCE AND DIVERSITY OF THEIR INTERVIEWER. THE STUDY WAS LED BY PROFESSOR TERRENCE SEJNOWSKI AND PUBLISHED IN NEURAL COMPUTATION ON FEBRUARY 17, 2023. NEW COMBINATION OF DRUGS WORKS TOGETHER TO REDUCE LUNG TUMORS IN MICE - STANDARD CHEMOTHERAPY AND IMMUNOTHERAPY TREATMENTS ARE NOT EFFECTIVE AGAINST NON-SMALL CELL LUNG CANCERS (NSCLCS) THAT HAVE AN LKB1 GENETIC MUTATION. A NEW STUDY REVEALED FDA-APPROVED TRAMETINIB AND ENTINOSTAT (WHICH IS CURRENTLY IN CLINICAL TRIALS) CAN BE GIVEN IN TANDEM TO PRODUCE FEWER AND SMALLER TUMORS IN MICE WITH LKB1-MUTATED NSCLC. THE STUDY WAS LED BY PROFESSOR REUBEN SHAW AND PUBLISHED IN SCIENCE ADVANCES ON MARCH 17, 2023.
Form 990, Part III, Line 4a continued3WEARABLE MICROSCOPES ADVANCE SPINAL CORD IMAGING IN MICE - WHILE THE SPINAL CORD IS KNOWN TO PLAY AN ESSENTIAL ROLE IN RELAYING PAIN SIGNALS, TECHNOLOGY HAS LIMITED SCIENTISTS' UNDERSTANDING OF HOW THIS PROCESS OCCURS ON A CELLULAR LEVEL. SALK SCIENTISTS CREATED WEARABLE MICROSCOPES TO ENABLE UNPRECEDENTED INSIGHT INTO THE SIGNALING PATTERNS THAT OCCUR WITHIN THE SPINAL CORDS OF MICE. THESE TECHNOLOGICAL ADVANCEMENTS WILL HELP RESEARCHERS BETTER UNDERSTAND THE NEURAL BASIS OF SENSATIONS AND MOVEMENT IN HEALTHY AND DISEASE CONTEXTS, SUCH AS CHRONIC PAIN, ITCH, AMYOTROPHIC LATERAL SCLEROSIS (ALS), OR MULTIPLE SCLEROSIS (MS). THE STUDIES WERE LED BY ASSOCIATE PROFESSOR AXEL NIMMERJAHN AND PUBLISHED IN NATURE COMMUNICATIONS ON MARCH 21, 2023, AND NATURE BIOTECHNOLOGY ON MARCH 6, 2023. NOT ALL ITCHES ARE THE SAME, ACCORDING TO THE BRAIN - RESEARCH BY SALK INSTITUTE SCIENTISTS REVEALED A DEDICATED BRAIN PATHWAY THAT DRIVES THE MECHANICAL SENSATION OF ITCH (E.G., THE SENSATION OF A MOSQUITO CRAWLING ON YOUR ARM) AND IS DISTINCT FROM THE NEURAL PATHWAY THAT ENCODES THE CHEMICAL SENSATION OF ITCH (E.G., FROM THE MOSQUITO'S SALIVA AFTER A BITE). THEY FOUND THAT A SMALL POPULATION OF NEURONS RELAYS MECHANICAL ITCH INFORMATION FROM THE SPINAL CORD TO THE BRAIN AND ALSO IDENTIFIED THE NEUROPEPTIDE SIGNALS THAT REGULATE BOTH ITCH TYPES. THE FINDINGS OPEN NEW AVENUES FOR THERAPEUTIC INTERVENTIONS FOR CHRONIC ITCH CONDITIONS, INCLUDING ATOPIC DERMATITIS AND PSORIASIS. THE STUDY WAS LED BY PROFESSOR MARTYN GOULDING AND ASSISTANT PROFESSOR SUNG HAN, AND PUBLISHED IN NEURON ON APRIL 5, 2023. MITOCHONDRIA POWER-SUPPLY FAILURE MAY CAUSE AGE-RELATED COGNITIVE IMPAIRMENT - RESEARCHERS AT THE SALK INSTITUTE FOUND THAT THE LOSS OF SYNAPSES BETWEEN NEURONS OCCURS WITH BOTH HEALTHY AND MEMORY-IMPAIRED AGING, BUT WHAT DIFFERS IS THE BREAKDOWN IN THE STANDARD CORRELATION BETWEEN THE SIZES OF SYNAPTIC BOUTONS AND THE MITOCHONDRIA INSIDE. THE FINDINGS HIGHLIGHT THIS VIOLATION OF THE ULTRASTRUCTURAL SIZE PRINCIPLE AND MITOCHONDRIA-RELATED FAILURES AS THE KEY TO AGE-RELATED COGNITIVE IMPAIRMENT, USHERING IN A NEW ERA FOR AGING RESEARCH. THE STUDY WAS LED BY PROFESSOR JOHN REYNOLDS AND PUBLISHED IN FRONTIERS IN AGING NEUROSCIENCE ON APRIL 12, 2023. CRACKING THE CASE OF MITOCHONDRIAL REPAIR AND REPLACEMENT IN METABOLIC STRESS - WHEN CELLULAR ENERGY LEVELS DIP, THE CELL RESPONSE TO THIS METABOLIC STRESS IS TO GET RID OF THE DAMAGED MITOCHONDRIA AND CREATE NEW ONES-BUT HOW THIS OCCURS REMAINED UNCLEAR. SCIENTISTS AT THE SALK INSTITUTE FOUND THAT A PROTEIN CALLED FNIP1 IS THE CRITICAL LINK BETWEEN A CELL SENSING LOW ENERGY LEVELS AND ELIMINATING AND REPLACING DAMAGED MITOCHONDRIA. THIS FUNDAMENTAL DISCOVERY CAN HELP US UNDERSTAND HEALTHY AGING, CANCEROUS TUMORS, NEURODEGENERATIVE DISEASES, AND MORE. THE STUDY WAS LED BY PROFESSOR REUBEN SHAW AND PUBLISHED IN SCIENCE ON APRIL 20, 2023. HOW AN AGGRESSION-PROMOTING BRAIN PEPTIDE WORKS IN FRUIT FLIES - SALK RESEARCHERS SHOWED HOW NEUROPEPTIDES RELEASED FROM A SMALL GROUP OF NEURONS CAN RESHAPE ACTIVITY PATTERNS IN MULTIPLE DOWNSTREAM BRAIN AREAS IN THE FLY AND IMPACT THE ANIMAL'S BEHAVIOR. THE FINDINGS ARE AN IMPORTANT STEP TO UNDERSTANDING HOW VARIABLE RESPONSES TO NEUROPEPTIDES CONTRIBUTE TO HUMAN CONDITIONS LIKE AUTISM-SPECTRUM DISORDER OR ATTENTION-DEFICIT DISORDERS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR KENTA ASAHINA AND PUBLISHED IN THE JOURNAL OF NEUROSCIENCE ON MAY 10, 2023. A NEW MODEL OF STUDYING HUMAN BRAIN IMMUNE CELLS AND NEUROLOGICAL DISORDERS - UNLIKE SOME HUMAN CELLS THAT CAN BE STUDIED OUTSIDE OF THE BODY OR IN NONHUMAN MODELS, HUMAN MICROGLIA ARE DIFFICULT TO STUDY WHEN REMOVED FROM THE HUMAN-BRAIN-LIKE ENVIRONMENT. TO OVERCOME THIS BARRIER, SALK SCIENTISTS DEVELOPED AN ORGANOID MODEL THAT ALLOWS RESEARCHERS TO STUDY HUMAN MICROGLIAL DEVELOPMENT AND FUNCTION FOR THE FIRST TIME IN LIVING HUMAN-DERIVED TISSUE. THE SCIENTISTS ALSO EXAMINED PATIENT-DERIVED MICROGLIA FROM CHILDREN WITH MACROCEPHALIC AUTISM SPECTRUM DISORDER, HIGHLIGHTING THE IMPORTANCE OF IMMUNE CELL AND BRAIN INTERACTIONS IN NEURODEGENERATIVE AND DEVELOPMENTAL DISEASES. THE STUDY WAS LED BY PROFESSOR RUSTY GAGE AND PUBLISHED IN CELL ON MAY 11, 2023. SEEING THE INSIDES OF PLANTS IN 3D - SALK SCIENTISTS DEVELOPED A NEW TECHNOLOGY THAT CAN CAPTURE THE INTERNAL PLANT WORLD AT AN UNPRECEDENTED RESOLUTION, OPENING THE DOOR FOR UNDERSTANDING HOW PLANTS RESPOND TO A CHANGING CLIMATE. THE METHOD, CALLED PHYTOMAP, CAN CAPTURE ENTIRE PLANT TISSUES (LIKE THE WHOLE ROOT TIP), INSTEAD OF A SMALL SLICE, AND PROVIDES INSIGHT INTO THE COMPLEX BIOLOGICAL CONVERSATIONS BETWEEN CELLS THAT IS DIFFICULT IN TWO DIMENSIONS. THE STUDY WAS LED BY PROFESSOR JOSEPH ECKER AND PUBLISHED IN NATURE PLANTS ON JUNE 12, 2023. MAPPING THE DEVELOPMENT OF INFECTION-FIGHTING IMMUNE CELLS - SPECIALIZED IMMUNE CELLS, CALLED CYTOTOXIC T CELLS, CAN DEVELOP INTO SHORT-LIVED EFFECTOR CELLS THAT KILL INFECTED OR CANCEROUS CELLS WITHIN OUR BODIES. A SMALL PORTION OF THOSE EFFECTOR CELLS REMAIN AFTER AN INFECTION AND BECOME LONGER-LIVED MEMORY CELLS. SALK SCIENTISTS DISCOVERED THAT A PROTEIN COMPLEX CALLED CBAF CAN OPEN OR CLOSE GENETIC "DOORS" TO CONTROL WHETHER A T CELL BECOMES AN EFFECTOR OR A MEMORY CELL. THE FINDINGS ILLUMINATE HOW T CELLS FIGHT AND REMEMBER INFECTIONS AND PAVE THE WAY FOR THE DEVELOPMENT OF MORE EFFECTIVE VACCINES AND CANCER THERAPEUTICS. THE STUDY WAS LED BY PROFESSOR SUSAN KAECH AND ASSOCIATE PROFESSOR DIANA HARGREAVES, AND PUBLISHED IN IMMUNITY ON JUNE 13, 2023. ALL THE IMMUNITY, NONE OF THE SYMPTOMS - SALK SCIENTISTS DISCOVERED THAT, IN MICE, PAIRING DISEASE-CAUSING BACTERIA WITH SPECIFIC DIETARY INTERVENTIONS CREATES LONG-TERM IMMUNITY, REVEALING A NEW POTENTIAL VACCINATION STRATEGY FOR DIARRHEAL DISEASES LIKE E. COLI. THE STUDY WAS LED BY PROFESSOR JANELLE AYRES AND PUBLISHED IN SCIENCE ADVANCES ON JUNE 23, 2023.
Form 990, Part VI, Line 1a Delegate broad authority to a committeeTHE EXECUTIVE COMMITTEE SHALL ADVISE AND AID THE OFFICERS OF THE CORPORATION IN ALL MATTERS CONCERNING ITS INTERESTS, INCLUDING WITHOUT LIMITATION ALL MATTERS RELATING TO COMPENSATION AND BENEFITS, AND SHALL POSSESS AND MAY EXERCISE, DURING THE INTERVALS BETWEEN THE MEETINGS OF THE BOARD OF TRUSTEES, ALL THE POWERS AND AUTHORITY OF THE BOARD OF TRUSTEES IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE CORPORATION, INCLUDING THE POWER TO AUTHORIZE THE CORPORATE SEAL TO BE AFFIXED TO ANY AND ALL DOCUMENTS WHICH MAY REQUIRE THE SAME TO BE AFFIXED THERETO, INSOFAR AS SUCH SEEMS TO THE EXECUTIVE COMMITTEE FOR THE BEST INTERESTS OF THE CORPORATION, IN ALL CASES IN WHICH SPECIFIC DIRECTIONS SHALL NOT HAVE BEEN GIVEN BY THE BOARD OF TRUSTEES, EXCEPT THAT THE EXECUTIVE COMMITTEE SHALL HAVE NO POWER TO ADOPT, AMEND, OR REPEAL THE BY-LAWS.
Form 990, Part VI, Line 6 Classes of members or stockholdersMEMBERSHIP OF THE CORPORATION CONSISTS OF THE PERSONS ELECTED TO THE BOARD OF TRUSTEES AND THREE MEMBERS FROM AMONG THE RESIDENT AND NON-RESIDENT FELLOWS AND PROFESSORS CHOSEN AND ELECTED ANNUALLY BY THE RESIDENT AND NON-RESIDENT FELLOWS AND PROFESSORS.
Form 990, Part VI, Line 7a Members or stockholders electing members of governing bodyTHE MEMBERS OF THE CORPORATION ELECT THE TRUSTEES.
Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholdersTHE MEMBERS OF THE CORPORATION MAY ALTER, AMEND, OR REPEAL THE BY-LAWS BY VOTE.
Form 990, Part VI, Line 11b Review of form 990 by governing bodyTHE FORM 990 IS PREPARED BY THE INSTITUTE, INTERNALLY REVIEWED BY THE CHIEF FINANCIAL OFFICER AND EXTERNALLY REVIEWED BY THE TAX DEPARTMENT OF A PUBLIC ACCOUNTING FIRM. PRIOR TO ELECTRONIC FILING, A COPY OF THIS FORM 990 IS PROVIDED TO AND DISCUSSED IN THE EXECUTIVE SESSION OF THE BOARD OF TRUSTEES.
Form 990, Part VI, Line 12c Conflict of interest policyANNUALLY, THE CONFLICT OF INTEREST DISCLOSURE STATEMENT IS SENT OUT FOR COMPLETION BY THE MEMBERS OF THE BOARD OF TRUSTEES, SENIOR MEMBERS OF ADMINISTRATION AND RESEARCHERS. THE DESIGNATED OFFICIAL FOR EACH GROUP REVIEWS THE COMPLETED FORMS AND BRINGS ANY POTENTIAL CONFLICT OF INTEREST TO THE RESPECTIVE COMMITTEES FOR REVIEW. UPON DETERMINATION THAT A CONFLICT OF INTEREST EXISTS, THE FOLLOWING CONDITIONS OR RESTRICTIONS MAY BE IMPOSED: A. MONITORING OF ACTIVITIES GENERATING THE CONFLICT BY ANOTHER MEMBER; B. DISQUALIFICATION FROM PARTICIPATION IN THE ACTIVITIES GIVING RISE TO THE CONFLICT; C. MODIFICATION OF RESPONSIBILITIES TO AVOID CONFLICTS; D. PUBLIC DISCLOSURE OR DIVESTITURE OF SIGNIFICANT FINANCIAL INTERESTS; E. MODIFICATION OF THE RESEARCH PLAN OR REMOVAL OF THE AFFECTED RESEARCHER FROM THE RESEARCH; F. SEVERANCE OF RELATIONSHIP THAT CREATES ACTUAL OR POTENTIAL CONFLICTS; G. TERMINATION OF EMPLOYMENT.
Form 990, Part VI, Line 15a Process to establish compensation of top management officialA COMPREHENSIVE MARKET ASSESSMENT WAS COMPLETED IN APRIL 2023 BASED ON DATA FROM A SELECTED PEER GROUP AND HISTORICAL OVERALL MARKET DATA FOR SALK PRESIDENT AND EXECUTIVE LEADERSHIP ROLES. THIS REPORT WAS PROVIDED TO THE CHAIR AND CO-CHAIRS OF SALK'S BOARD OF TRUSTEES AND TO SALK'S CURRENT PRESIDENT AND PREVIOUS PRESIDENT. SALK'S PRESIDENT FOR THE PERIOD THROUGH APRIL 2023 DISCUSSED THE PERFORMANCE OF EACH VICE-PRESIDENT LEVEL EXECUTIVE AT A SPECIAL MEETING HELD ON JUNE 13, 2023, WITH THE CHAIR AND CO-CHAIR OF THE BOARD OF DIRECTORS AND SALK'S CURRENT PRESIDENT. AFTER DISCUSSION, RECOMMENDED CHANGES WERE APPROVED FOR VICE-PRESIDENT LEVEL INCUMBENTS ON SALK'S EXECUTIVE LEADERSHIP TEAM. NO CHANGES WERE RECOMMENDED FOR THE SALK PRESIDENT ROLE DUE TO THE LIMITED TENURE OF THE INCUMBENT. ALL COMPENSATION CHANGES WERE EFFECTIVE JULY 1, 2023.
Form 990, Part VI, Line 15b Process to establish compensation of other employeesA COMPREHENSIVE MARKET ASSESSMENT WAS COMPLETED IN APRIL 2023 BASED ON DATA FROM A SELECTED PEER GROUP AND HISTORICAL OVERALL MARKET DATA FOR SALK PRESIDENT AND EXECUTIVE LEADERSHIP ROLES. THIS REPORT WAS PROVIDED TO THE CHAIR AND CO-CHAIRS OF SALK'S BOARD OF TRUSTEES AND TO SALK'S CURRENT PRESIDENT AND PREVIOUS PRESIDENT. SALK'S PRESIDENT FOR THE PERIOD THROUGH APRIL 2023 DISCUSSED THE PERFORMANCE OF EACH VICE-PRESIDENT LEVEL EXECUTIVE AT A SPECIAL MEETING HELD ON JUNE 13, 2023, WITH THE CHAIR AND CO-CHAIR OF THE BOARD OF DIRECTORS AND SALK'S CURRENT PRESIDENT. AFTER DISCUSSION, RECOMMENDED CHANGES WERE APPROVED FOR VICE-PRESIDENT LEVEL INCUMBENTS ON SALK'S EXECUTIVE LEADERSHIP TEAM. NO CHANGES WERE RECOMMENDED FOR THE SALK PRESIDENT ROLE DUE TO THE LIMITED TENURE OF THE INCUMBENT. ALL COMPENSATION CHANGES WERE EFFECTIVE JULY 1, 2023.
Form 990, Part VI, Line 19 Required documents available to the publicUPON REQUEST, THE OFFICE OF THE CHIEF FINANCIAL OFFICER MAKES AVAILABLE TO THE PUBLIC THE INSTITUTE'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY. FINANCIAL STATEMENTS ARE AVAILABLE ON THE SALK WEBSITE.
Form 990, Part VII, Section A DIRECTORS COMPENSATIONTHE FOLLOWING INDIVIDUALS WERE COMPENSATED FOR THE FOLLOWING SERVICES AND NOT PAID AS TRUSTEES: FRED GAGE, PH.D. - PRESIDENT/PROFESSOR; REUBEN SHAW, PH.D. - PROFESSOR; MARTYN GOULDING, PH.D. - PROFESSOR; TATYANA SHARPEE, PH.D. - PROFESSOR.
Form 990, Part VIII, Line 11d Other Miscellaneous RevenueA/R RECHARGE ALLOWANCE - Total Revenue: -269603, Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: -269603;
Form 990, Part XI, Line 9 Other changes in net assets or fund balancesPOSTRETIREMENT BENEFIT CHANGES OTHER THAN NET PERIODIC BENEFIT COST - 726028; CHANGE IN VALUE OF DEFERRED GIFTS - -46590; ROUNDING - -2;

Schedule R IRS990ScheduleR

Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtEntity TypeEntityTypeTxtShare Of Total IncomeShareOfTotalIncomeAmtShare Of EOY AssetsShareOfEOYAssetsAmtOwnershipOwnershipPctControlled OrganizationControlledOrganizationInd
SALK INSTITUTE COMMERCIAL SERVICES CORP
10010 N TORREY PINES ROADLA JOLLACA920371002232159172MGMT SERVICESPASALK INSTITUTEC Corporation$4$41,1381.0000Yes (true)
CHARITABLE REMAINDER TRUSTS (5)
SUPPORTCANATrust
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgfalseGiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (true)SharingOfFacilitiesInd
Paid Employees SharingYes (true)PaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgYes (true)ReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.